Founded in 2007, Discuva, classified under reg no. 06169490 is an active company. Currently registered at 136a Eastern Avenue OX14 4SB, Abingdon the company has been in the business for seventeen years. Its financial year was closed on Tue, 31st Dec and its latest financial statement was filed on December 31, 2022. Since January 10, 2011 Discuva Limited is no longer carrying the name Omacrom.
The company has 3 directors, namely Manmeet S., Ankur D. and Robert D.. Of them, Robert D. has been with the company the longest, being appointed on 27 May 2020 and Manmeet S. has been with the company for the least time - from 6 December 2023. At present there are several former directors listed by the company. In addition, the company lists several former secretaries. The full list of both former directors and former secretaries might be found in the box below.
| Office Address | 136a Eastern Avenue |
| Office Address2 | Milton Park |
| Town | Abingdon |
| Post code | OX14 4SB |
| Country of origin | United Kingdom |
| Registration Number | 06169490 |
| Date of Incorporation | Mon, 19th Mar 2007 |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 31st December |
| Company age | 17 years old |
| Account next due date | Mon, 30th Sep 2024 (124 days left) |
| Account last made up date | Sat, 31st Dec 2022 |
| Next confirmation statement due date | Tue, 2nd Apr 2024 (2024-04-02) |
| Last confirmation statement dated | Sun, 19th Mar 2023 |
Position: Director
Appointed: 06 December 2023
Position: Director
Appointed: 18 August 2022
Position: Director
Appointed: 27 May 2020
The register of persons with significant control that own or have control over the company consists of 2 names. As BizStats found, there is Summit Therapeutics Limited from Abingdon, England. This PSC is categorised as "a limited company", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares. Another entity in the persons with significant control register is New Wave Ventures Llp that put London, England as the address. This PSC has a legal form of "a limited liability partnership", owns 50,01-75% shares, has 25-50% voting rights. This PSC owns 50,01-75% shares and has 25-50% voting rights.
Summit Therapeutics Limited
136a Eastern Avenue, Milton Park, Abingdon, OX14 4SB, England
| Legal authority | England And Wales |
| Legal form | Limited Company |
| Country registered | United Kingdom |
| Place registered | England And Wales |
| Registration number | 05197494 |
| Notified on | 23 December 2017 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
New Wave Ventures Llp
Eighth Floor 6 New Street Square, London, EC4A 3AQ, England
| Legal authority | Limited Liability Partnerships Act 2000 |
| Legal form | Limited Liability Partnership |
| Country registered | England |
| Place registered | England |
| Registration number | Oc352180 |
| Notified on | 6 April 2016 |
| Ceased on | 23 December 2017 |
| Nature of control: |
50,01-75% shares 25-50% voting rights |
| Omacrom | January 10, 2011 |
| Profit & Loss | |||||
|---|---|---|---|---|---|
| Accounts Information Date | 2013-03-31 | 2014-03-31 | 2015-03-31 | 2016-03-31 | 2017-03-31 |
| Net Worth | -1 091 923 | -634 245 | 1 174 417 | 2 271 137 | |
| Balance Sheet | |||||
| Cash Bank On Hand | 5 282 074 | 2 527 442 | |||
| Current Assets | 2 117 792 | 9 481 870 | 7 692 894 | 5 657 309 | 3 424 834 |
| Debtors | 240 084 | 1 070 619 | 63 727 | 375 235 | 897 392 |
| Net Assets Liabilities | 2 271 137 | 2 366 511 | |||
| Property Plant Equipment | 3 430 017 | 3 368 575 | |||
| Cash Bank In Hand | 1 877 708 | 8 155 019 | 7 629 167 | 5 282 074 | |
| Net Assets Liabilities Including Pension Asset Liability | -1 091 923 | -634 245 | 1 174 417 | 2 271 137 | |
| Tangible Fixed Assets | 284 487 | 3 128 711 | 3 182 196 | 3 430 017 | |
| Reserves/Capital | |||||
| Called Up Share Capital | 21 787 | 21 787 | 21 787 | 21 787 | |
| Profit Loss Account Reserve | -1 113 710 | -656 032 | 1 152 630 | 2 249 350 | |
| Shareholder Funds | -1 091 923 | -634 245 | 1 174 417 | 2 271 137 | |
| Other | |||||
| Accumulated Depreciation Impairment Property Plant Equipment | 532 658 | 787 279 | |||
| Average Number Employees During Period | 24 | 23 | |||
| Creditors | 3 101 679 | 572 913 | |||
| Fixed Assets | 284 487 | 3 128 711 | 3 182 196 | 3 430 017 | 3 368 575 |
| Increase From Depreciation Charge For Year Property Plant Equipment | 254 621 | ||||
| Net Current Assets Liabilities | 2 016 910 | -252 362 | 4 365 716 | 2 580 018 | 2 851 921 |
| Property Plant Equipment Gross Cost | 3 962 675 | 4 155 854 | |||
| Total Additions Including From Business Combinations Property Plant Equipment | 193 179 | ||||
| Total Assets Less Current Liabilities | 2 301 397 | 11 949 399 | 7 547 912 | 6 010 035 | 6 220 496 |
| Accruals Deferred Income | 9 075 237 | 5 842 364 | |||
| Creditors Due After One Year | 3 393 320 | 3 508 407 | 3 623 495 | 3 738 898 | |
| Creditors Due Within One Year | 100 882 | 662 609 | 3 341 734 | 3 101 679 | |
| Non-instalment Debts Due After5 Years | 3 393 320 | 3 508 407 | |||
| Number Shares Allotted | 21 786 493 | 21 786 493 | 21 786 493 | ||
| Other Debtors Due After One Year | 240 084 | 1 326 851 | 63 727 | 375 235 | |
| Par Value Share | 0 | 0 | 0 | ||
| Prepayments Accrued Income Not Expressed Within Current Asset Subtotal | 257 159 | 14 556 | 24 388 | ||
| Share Capital Allotted Called Up Paid | 21 786 | 21 786 | 21 786 | 21 786 | |
| Tangible Fixed Assets Additions | 2 916 530 | 238 606 | 475 808 | ||
| Tangible Fixed Assets Cost Or Valuation | 331 731 | 3 248 261 | 3 486 867 | 3 962 675 | |
| Tangible Fixed Assets Depreciation | 47 244 | 119 550 | 304 671 | 532 658 | |
| Tangible Fixed Assets Depreciation Charged In Period | 72 306 | 185 121 | 227 987 | ||
| Type | Category | Free download | |
|---|---|---|---|
| SH19 |
Capital declared on March 12, 2024: 0.00 GBP filed on: 12th, March 2024 |
capital | Free Download (5 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy